ImmuPharma plc (IMMPF) Stock Analysis
DELISTED
What happened to ImmuPharma plc (IMMPF) stock?
ImmuPharma plc (IMMPF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $28.3M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
ImmuPharma plc (IMMPF). ImmuPharma plc is a biopharmaceutical company focused on discovering and developing peptide-based therapeutics for autoimmune, inflammatory, and anti-infective diseases. Their lead product, Lupuzor, is in Phase III clinical trials for lupus treatment.
Last analyzed: Mar 18, 2026ImmuPharma plc (IMMPF) Healthcare & Pipeline Overview
IMMPF OTC Market Information
IMMPF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy IMMPF shares?
No. IMMPF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IMMPF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before IMMPF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ImmuPharma plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.